Internal Medicine, Hematology & Oncology · New Hyde Park, NY
NPI
1124472873
Since 2016
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1 Delaware Dr
New Hyde Park, NY, 11042
Phone (516) 336-5255
Groups this clinician bills Medicare through
Medicare paid, 2024
$880K
56,826 services
Medicare patients, 2024
636
Average age 75
Drug cost, 2024
$2.4M
800 prescriptions
Company payments, 2025
$2,502
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adam Hines was code J1439 (injection, ferric carboxymaltose, 1 mg), 21,000 times for 20 patients. In total Adam Hines billed 56,826 services in 173 codes, and Medicare paid $880K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 21,000 | 20 | $0.88 | $18K |
| J1756 Injection, iron sucrose, 1 mg | Office | 3,600 | 11 | $0.18 | $646 |
| J0897 Injection, denosumab, 1 mg | Office | 1,860 | 14 | $20.35 | $38K |
| 99233 Hospital E&M - Subsequent | Facility | 863 | 294 | $103.41 | $89K |
| 88185 Surgical Pathology Examination | Office | 855 | 36 | $22.14 | $19K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 806 | 35 | $0.09 | $72.71 |
| 36415 Venipuncture Blood Collection | Office | 747 | 310 | $8.65 | $6,462 |
| 85025 Blood Count | Office | 723 | 303 | $7.59 | $5,487 |
| 80053 Clinical Chemistry | Office | 550 | 252 | $10.33 | $5,682 |
| 83615 Clinical Chemistry | Office | 405 | 199 | $5.91 | $2,392 |
| 99214 Office E&M - Established | Office | 388 | 161 | $108.82 | $42K |
| 82784 Immunoassay | Office | 345 | 72 | $9.11 | $3,144 |
| 84550 Clinical Chemistry | Office | 338 | 181 | $4.42 | $1,493 |
| 82728 Clinical Chemistry | Office | 277 | 149 | $13.31 | $3,687 |
| 83540 Clinical Chemistry | Office | 276 | 150 | $6.32 | $1,744 |
By year: 2023 $548K for 46,031 services; 2024 $880K for 56,826 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 855 | 36 | $22.14 | $19K |
| 36415 Venipuncture Blood Collection | 747 | 310 | $8.65 | $6,462 |
| 85025 Blood Count | 723 | 303 | $7.59 | $5,487 |
| 80053 Clinical Chemistry | 550 | 252 | $10.33 | $5,682 |
| 83615 Clinical Chemistry | 405 | 199 | $5.91 | $2,392 |
| 82784 Immunoassay | 345 | 72 | $9.11 | $3,144 |
| 84550 Clinical Chemistry | 338 | 181 | $4.42 | $1,493 |
| 82728 Clinical Chemistry | 277 | 149 | $13.31 | $3,687 |
| 83540 Clinical Chemistry | 276 | 150 | $6.32 | $1,744 |
| 83550 Clinical Chemistry | 272 | 146 | $8.54 | $2,322 |
Medicare prescription drug claims, 2024
In 2024, the drug Adam Hines prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 60 prescriptions and refills. In total Adam Hines wrote 800 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 60 | 61 | 19 | $157K |
| Akynzeo Fosnetupitant/Palonosetron | 51 | 51 | 11 | $56K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 43 | 43 | Under 11 | $624K |
| Eliquis Apixaban | 38 | 44 | Under 11 | $25K |
| Famotidine Generic | 27 | 35 | 14 | $80.93 |
| Prednisone Generic | 26 | 31 | Under 11 | $93.76 |
| Hydroxyurea Generic | 22 | 32 | Under 11 | $561 |
| Neulasta Onpro Pegfilgrastim | 21 | 21 | Under 11 | $129K |
| Letrozole Generic | 21 | 29 | Under 11 | $248 |
| Xgeva Denosumab | 18 | 18 | Under 11 | $55K |
| Acyclovir Generic | 18 | 24 | Under 11 | $200 |
| Perjeta Pertuzumab | 18 | 18 | Under 11 | $136K |
| Ontruzant Trastuzumab-Dttb | 18 | 18 | Under 11 | $91K |
| Xarelto Rivaroxaban | 17 | 19 | Under 11 | $10K |
| Ondansetron Odt Ondansetron | 16 | 16 | 11 | $208 |
Brand drugs: 414 claims; generic drugs: 386 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adam Hines $2,502 ($2,502 in general payments such as food, travel and fees) from 4 companies. The largest payer was Pfizer Inc. with $2,221.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.